Dans un article de L'EXPRESS, la journaliste Stéphanie Benz s'interroge sur l'explosion du marché des "médicaments orphelins", Pourquoi les prix des traitements contre les maladies rares deviennent fous, au "risque...
Kirk Kerr and Lukas Glos, economist at the Center for Drug Evaluation and Research, U.S. Food and Drug Administration, are publishing in Pharmaceutical Medicine, an article on Effective Market...
The pharmaceutical industry is responsible for a large proportion of R&D investments on which the availability of future innovation depends. But there are areas facing a serious threat of underinvestment...